Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy + Anakinra in Resectable Pancreatic Adenocarcinoma
NCT04926467Phase 2Recruiting
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Jul 2021
- Primary completion
- Jun 2027
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in pancreatic adenocarcinoma (PDAC), sponsored by Baylor Scott & White Research Institute. Started Jul 2021; status: recruiting.
02
Drugs
anakinra
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT04926467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04926467.